EP300 and neoplasm: In particular, STAT3 has been shown to physically interact with HIF-1α and co-recruit p300/CREB-binding protein (p300/CBP) and RNA-Polymerase II to the vascular endothelial growth factor (VEGFA) promoter in hypoxic tumor cells, thereby reinforcing transcription of angiogenic genes.